MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
FOXO4-DRI For Lab Research 194.99 Login for member prices FOXO4-DRI is a D-retro-inverso senolytic peptide for laboratory and in vitro research into apoptosis of senescent cells
It also activates focal adhesion kinase (FAK) and paxillin signalling, facilitating cell migration to wound sites
As peer-reviewed Phase 3 results publish, this guide is updated with the confirmed figures
Although B12 is naturally present in many foods, some individuals are unable to absorb it efficiently from their diet due to various underlying conditions
Adocia holds more than 25 patent families
